Abbott Expands Cardiovascular Innovations in India Amid Rising Heart Disease Rates
Abbott Bets Big On India's Cardiovascular Market, Eyes Faster Global-To-India Tech Launches
News 18
Image: News 18
Abbott Laboratories, an American medical device company, is intensifying its focus on India's cardiovascular market due to a significant rise in heart disease cases among younger populations. With nearly 60% of global heart disease cases originating from India, Abbott aims to accelerate the launch of advanced technologies and improve access to care across the country.
- 01Abbott is prioritizing India in its global cardiovascular strategy due to the high prevalence of heart disease.
- 02The company is focusing on early detection and minimally invasive technologies to improve patient outcomes.
- 03Abbott's innovations include advanced diagnostics and new treatment devices, allowing for quicker recovery.
- 04The firm has been in India for over 115 years, emphasizing its long-term commitment beyond just manufacturing.
- 05Investment in local capabilities and pediatric care is a key part of Abbott's strategy in India.
Advertisement
In-Article Ad
Abbott Laboratories, a leading American medical device company, is responding to India’s urgent cardiovascular health crisis, which sees nearly 60% of global heart disease cases. Tushar Sharma, managing director for Abbott's vascular business in India and South Asia, highlighted that heart disease is increasingly affecting younger individuals, necessitating timely diagnosis and intervention. Abbott's strategy focuses on three pillars: earlier detection through AI-enabled diagnostics, faster access to minimally invasive technologies, and expanding care to smaller cities. Innovations such as the Navitor Vision for transcatheter aortic valve replacement and AVEIR leadless pacemakers exemplify this commitment. Furthermore, Abbott is transforming recovery for cardiac patients with new vessel closure devices, allowing for same-day discharge after procedures. With over 115 years in India, Abbott aims to strengthen its healthcare ecosystem and invest in local talent and technology, positioning India as a long-term partner in its global cardiovascular strategy.
Advertisement
In-Article Ad
Abbott's advancements in cardiovascular care could significantly improve health outcomes for patients in India, particularly among younger populations facing rising heart disease rates.
Advertisement
In-Article Ad
Reader Poll
How important is it for companies to invest in healthcare innovations in India?
Connecting to poll...
Read the original article
Visit the source for the complete story.